Empty Capsules Market 2023 – 2030 By End User (Pharmaceutical Manufacturers, Nutraceutical Manufacturers, and Others),Product (Gelatin Capsules and Non-Gelatin Capsules), Raw Material (Pig Meat, Bovine Meat, Bone, Hydroxypropyl Methylcellulose, and Others), Therapeutic Application (Antibiotic & Antibacterial Drugs, Vitamin & Dietary Supplements, Antacids & Anti-flatulent preparations, Cardiac Therapy Drugs, and Others) - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Industry : Healthcare | Pages : 187 Pages | Published On : Jul 2023
The global market for empty capsules reached a value of $2,382.7 million in 2020 and is projected to reach $5,230.4 million by 2030, growing at a CAGR of 8.1% from 2023 to 2030. Capsules are solid pharmaceutical dosage forms that enclose drugs or drug combinations within a shell. Empty capsules are commonly used for storing powders, drugs, and herbs, offering easier swallowing compared to tablets. Pharmaceutical manufacturers utilize empty capsules to prepare various therapeutic drugs. These capsules are made of gelatin or non-gelatin materials (such as pullulan, HPMC, and starch) and are available in different shapes, sizes, and colors. Hard gelatin capsules, composed of gelatin and purified water, are widely used in the pharmaceutical industry.
The COVID-19 pandemic has negatively impacted the global empty capsules market. The strain on healthcare systems worldwide and the need for diagnostic instruments and treatment centers for humans have disrupted the manufacturing sector due to limited movements of goods, services, and government regulations. The pharmaceutical and biotechnology industry, including the empty capsules market, has been affected by the pandemic.
The growth of the global empty capsules market is primarily driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, diabetes, and gastrointestinal diseases. There is also a rising demand for gelatin capsules, increased funding from private and government organizations for capsule manufacturing units, and a surge in research and development activities for the development of therapeutic products encapsulated in capsules.
The increasing number of chronic diseases and the demand for therapeutic drugs encapsulated in gelatin and soft gelatin empty capsules contribute to the market's growth. Additionally, the popularity of capsule drug delivery forms, the focus on healthcare supplements for maintaining good health, and the rise in clinical studies evaluating the safety and efficacy of therapeutic drugs drive market growth. The growing elderly population, the need for immunity boosters and dietary supplements, and technological advancements in manufacturing plant-derived capsules also create opportunities for market expansion. Government initiatives to develop the pharmaceutical industry and the presence of key manufacturing companies further fuel market growth.
However, ethical concerns, price fluctuations related to gelatin materials, and stringent regulations in the pharmaceutical industry may limit the market's growth during the forecast period.
Global Empty Capsules Market Segmentation:
The global empty capsules market is segmented based on product, raw material, therapeutic application, end user, and region. The product segment includes gelatin capsules and non-gelatin capsules. The raw material segment is divided into pig meat, bovine meat, bone, hydroxypropyl methylcellulose (HPMC), and others. Therapeutic application categories consist of antibiotic & antibacterial drugs, vitamin & dietary supplements, antacids & anti-flatulent preparations, cardiac therapy drugs, and others. The end user segment is classified into pharmaceutical manufacturers, nutraceutical manufacturers, and others.
The empty capsules market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America, including the U.S., Canada, and Mexico, held a major share in 2020 and is expected to dominate during the forecast period. Asia-Pacific is projected to experience the highest growth rate, driven by an increase in the geriatric population and the demand for immunity booster products.
In terms of product, the gelatin capsules segment dominated the market in 2020 due to advancements in R&D activities and the advantages of gelatin capsules compared to other drug delivery forms. However, the non-gelatin capsules segment is expected to witness considerable growth, driven by the demand for HPMC capsules and the development of plant-derived capsule manufacturing units.
By therapeutic application, the antibiotic & antibacterial drugs segment was the major contributor in 2020 and is expected to maintain its lead. The vitamin & dietary supplements segment is projected to witness significant growth due to the increasing demand for immunity boosters, the rise in the geriatric population, and the surge in demand for nutraceutical products.
The pharmaceutical manufacturers segment dominated the market in terms of end users in 2020, with the trend expected to continue. The nutraceutical manufacturers segment is anticipated to experience considerable growth due to the increasing demand for healthcare supplements and government initiatives to promote awareness about dietary supplements.
Key players in the global empty capsules market include ACG Worldwide, Bright Pharma Caps Inc., CapsCanada Corporation, Lonza Group Ltd. (Capsugel), Medi-Caps Ltd., Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.), Roxlor LLC, Snail Pharma Industry Co. Ltd, Suheung Co., Ltd, and Sunil Healthcare Ltd.
Key Benefits for Stakeholders:
• The study provides an in-depth analysis of the empty capsules market, current trends, and future estimations to identify investment opportunities.
• A quantitative analysis of the market from 2023 to 2030 helps stakeholders capitalize on prevailing opportunities.
• Extensive analysis based on procedures and services assists in understanding industry trends.
• Thorough analysis of key players and their strategies helps understand the competitive outlook of the empty capsules market.
Empty Capsules Market Report Highlights
By Therapeutic Application
• Antibiotic & Antibacterial Drugs
• Vitamin & Dietary Supplements
• Antacids & Anti-Flatulent Preparations
• Cardiac Therapy Drugs
By End User
• Pharmaceutical Manufacturers
• Nutraceutical Manufacturers
• North America (U.S., Canada, Mexico)
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
• LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
• Gelatin Capsules
• Non-Gelatin Capsules
By Raw Material
• Pig Meat
• Bovine Meat
• Hydroxypropyl Methylcellulose (HPMC)
Table and Figures
At MarketDigits, we take immense pride in our 360° Research Methodology, which serves as the cornerstone of our research process. It represents a rigorous and comprehensive approach that goes beyond traditional methods to provide a holistic understanding of industry dynamics.
This methodology is built upon the integration of all seven research methodologies developed by MarketDigits, a renowned global research and consulting firm. By leveraging the collective strength of these methodologies, we are able to deliver a 360° view of the challenges, trends, and issues impacting your industry.
The first step of our 360° Research Methodology™ involves conducting extensive primary research, which involves gathering first-hand information through interviews, surveys, and interactions with industry experts, key stakeholders, and market participants. This approach enables us to gather valuable insights and perspectives directly from the source.
Secondary research is another crucial component of our methodology. It involves a deep dive into various data sources, including industry reports, market databases, scholarly articles, and regulatory documents. This helps us gather a wide range of information, validate findings, and provide a comprehensive understanding of the industry landscape.
Furthermore, our methodology incorporates technology-based research techniques, such as data mining, text analytics, and predictive modelling, to uncover hidden patterns, correlations, and trends within the data. This data-driven approach enhances the accuracy and reliability of our analysis, enabling us to make informed and actionable recommendations.
In addition, our analysts bring their industry expertise and domain knowledge to bear on the research process. Their deep understanding of market dynamics, emerging trends, and future prospects allows for insightful interpretation of the data and identification of strategic opportunities.
To ensure the highest level of quality and reliability, our research process undergoes rigorous validation and verification. This includes cross-referencing and triangulation of data from multiple sources, as well as peer reviews and expert consultations.
The result of our 360° Research Methodology is a comprehensive and robust research report that empowers you to make well-informed business decisions. It provides a panoramic view of the industry landscape, helping you navigate challenges, seize opportunities, and stay ahead of the competition.
In summary, our 360° Research Methodology is designed to provide you with a deep understanding of your industry by integrating various research techniques, industry expertise, and data-driven analysis. It ensures that every business decision you make is based on a well-triangulated and comprehensive research experience.
- Tailored advice to Drive your Performance
- Product Planning Strategy
- New Product Stratergy
- Expanded Research Scope
- Comprehensive Research
- Strategic Consulting
- Provocative and pragmatic
- Accelerate Revenue & Growth
- Evaluate the competitive landscape
- Optimize your partner network
- Analyzing industries
- Mapping trends
- Strategizing growth
- Implementing plans
Covered Key Topics
Market Growth Drivers
Leading Market Players
Company Market Share
Market Size and Growth Rate
Market Trend and Technological